Many with work-related asthma not getting key vaccine

September 27, 2017

(HealthDay)—Only half of American adults with work-related asthma get the recommended vaccination against pneumococcal disease, a new study finds.

Adults with asthma are at increased risk for pneumococcal disease, and the U.S. Centers for Disease Control and Prevention recommends that all adults aged 19 to 64 get the pneumococcal vaccine.

However, an analysis of 2012-13 national data found that only 54 percent of adults with work-related asthma got the shot.

The rate was lowest among Hispanics (36 percent), people without health insurance (39 percent), and adults aged 18 to 44 (42 percent).

The vaccination rate was even lower (35 percent) among adults with non-work-related asthma, according to the study by researchers at the CDC's National Institute for Occupational Safety and Health (NIOSH).

"Vaccination is the best way to prevent pneumococcal disease, including pneumonia, and CDC recommends that all adults with asthma, whether work-related or not, get the pneumococcal polysaccharide vaccine," NIOSH Director Dr. John Howard said in a CDC news release.

Each year, about 900,000 Americans get pneumococcal pneumonia, and 5 percent to 7 percent die from it, the CDC estimates. Adults with asthma who get pneumococcal pneumonia, a lung disease, are at risk for such complications as asthma exacerbation and .

Pneumococcal disease, an infection caused by Streptococcus pneumoniae, can cause many types of illnesses, including ear infections and meningitis.

"To increase the number of with asthma who are vaccinated against , we recommend that verify if their patients who have have received a and offer the vaccine to those not vaccinated," lead author Katelynn Dodd, an epidemiologist at NIOSH, said in the news release.

The findings were published Sept. 27 in the American Journal of Preventive Medicine.

Explore further: CDC finds vaccination coverage varies for adults with diabetes

More information: The U.S. Centers for Disease Control and Prevention has more on pneumococcal disease.

Related Stories

CDC finds vaccination coverage varies for adults with diabetes

December 12, 2016
(HealthDay)—Among adults with diagnosed diabetes, vaccination coverage varies, with influenza vaccination more prevalent than pneumococcal or hepatitis B vaccination, according to a December data brief published by the ...

Team publishes longitudinal work on pneumonia

July 10, 2017
A Marshall University Joan C. Edwards School of Medicine research team has published findings that show patients who recover from invasive pneumococcal pneumonia, on average, live 10 years less when measured against life ...

Seniors need two pneumonia vaccines, CDC advisory panel says

February 3, 2015
(HealthDay)—Adults 65 and older need two vaccines to better protect them from bacterial infection in the blood (called sepsis), meningitis and pneumonia, according to a revised vaccination schedule from the 2015 Advisory ...

Increased risk of pneumococcal pneumonia with hospital admission during school holidays

September 5, 2016
A study presented today (6 September 2016) at this year's European Respiratory Society (ERS) International Congress in London, UK shows that adults admitted to hospital during school holidays are 38% more likely to have pneumococcal ...

Nurses crucial in improving uptake of potentially life-saving vaccine in vulnerable RMD patients

June 15, 2017
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that implementing a vaccination programme run by nursing staff dramatically improves pneumococcal ...

Recommended for you

HIV vaccine protects non-human primates from infection

December 14, 2018
For more than 20 years, scientists at Scripps Research have chipped away at the challenges of designing an HIV vaccine. Now new research, published in Immunity, shows that their experimental vaccine strategy works in non-human ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

The 'greying' of T cells: Scientists pinpoint metabolic pathway behind age-related immunity loss

December 13, 2018
The elderly suffer more serious complications from infections and benefit less from vaccination than the general population. Scientists have long known that a weakened immune system is to blame but the exact mechanisms behind ...

Scientists create most accurate tool yet developed to predict asthma in young children

December 13, 2018
Scientists at Cincinnati Children's Hospital Medical Center have created and tested a decision tool that appears to be the most accurate, non-invasive method yet developed to predict asthma in young children.

New genetic study could lead to better treatment of severe asthma

December 12, 2018
The largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.

Researchers discover unique immune cell likely drives chronic inflammation

December 11, 2018
For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the general geriatric population ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.